Isomorphic Labs, Google’s artificial intelligence drug business, raised $600 million in its first external funding round, the company said on Monday.

While Alphabet stock fell 1.5% on Tuesday, its shares were up 4.7% at $171.67 in afternoon trading Wednesday. Wall Street analysts said the event showcased the company’s strength in AI development.

Alphabet is well positioned to take advantage of AI, and slipping search engine market share could help with the company's legal woes. See why GOOG stock is a Buy.